Literature DB >> 15124176

A review of cardiovascular complications accompanying AIDS.

A Pugliese1, L Gennero, V Vidotto, T Beltramo, S Petrini, D Torre.   

Abstract

Manifestations of cardiovascular system involvement are not uncommon complications of HIV infection, especially in AIDS patients. However, the frequency of these manifestations is influenced by different variables including: survival prolongation in HIV-infected patients, because of advances in antiretroviral treatment; improvement of immunodepression and reduction in the occurrence of opportunistic infections; adverse effects of some drugs. At present, on the whole cardiovascular complications that are HIV correlated in the western world, including Italy, occur less frequently than in the past. However complications associated with alterations in lipometabolism prevail because they can be promoted by some protease inhibitors in predisposed subjects. The most frequently reported questions and a careful analysis of recent data in the medical literature regarding the most common HIV-correlated cardiovascular complications are discussed in this review. Copyright 2004 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2004        PMID: 15124176     DOI: 10.1002/cbf.1095

Source DB:  PubMed          Journal:  Cell Biochem Funct        ISSN: 0263-6484            Impact factor:   3.685


  4 in total

Review 1.  Phagocytic activity in human immunodeficiency virus type 1 infection.

Authors:  Agostino Pugliese; Valerio Vidotto; Tiziana Beltramo; Donato Torre
Journal:  Clin Diagn Lab Immunol       Date:  2005-08

2.  Red Algal Sulfated Galactan Binds and Protects Neural Cells from HIV-1 gp120 and Tat.

Authors:  Vitor H Pomin; Fakhri Mahdi; Weihua Jin; Fuming Zhang; Robert J Linhardt; Jason J Paris
Journal:  Pharmaceuticals (Basel)       Date:  2021-07-23

3.  Acquired Long QT Syndrome and Torsade de Pointes Associated with HIV Infection.

Authors:  Alexander Shimabukuro-Vornhagen; Jan Rybniker; Shahram Zoghi; Gerd Faetkenheuer; Guido Michels; Erland Erdmann; Michael von Bergwelt-Baildon; Matthias Kochanek
Journal:  Case Rep Med       Date:  2010-08-23

4.  Efavirenz Inhibits the Human Ether-A-Go-Go Related Current (hERG) and Induces QT Interval Prolongation in CYP2B6*6*6 Allele Carriers.

Authors:  Ahmed M Abdelhady; Tyler Shugg; Nancy Thong; Jessica Bo Li Lu; Yvonne Kreutz; Heather A Jaynes; Jason D Robarge; James E Tisdale; Zeruesenay Desta; Brian R Overholser
Journal:  J Cardiovasc Electrophysiol       Date:  2016-07-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.